Rnf148^em2Zuk

CRISPR/Cas9 technology was used to target Rnf148 for deletion in zygotes containing the Rnf133em1Zuk allele (carrying a 1070 bp deletion) resulting in a double knock-out allele of both Rnf133 and Rnf148. (J:330415)